Bristol-Myers Squibb Pharmaceutical Limited

Bristol-Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH , UK
Telephone: +44 (0)1895 523 000
Fax: +44 (0)1895 523 010
Medical Information Direct Line: +44 (0)1895 523 740
Medical Information e-mail: medical.information@bms.com
Medical Information Fax: +44 (0)1895 523 677

Summary of Product Characteristics last updated on the eMC: 10/02/2010
SPC Nalorex

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/02/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Aug-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Date of Revisio of Text: August 2009

This has been amended to reflect that there were two separate updates - one in July 2009 reflecting the pack type and one in August 2009 regarding the storage condition.
Updated on 03/08/2009 and displayed until 10/02/2010
Reasons for adding or updating:
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   28-Jul-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

In section 6.4 (Special precautions for storage), 'Do not store above 30C. Store in the original package' has been changed to 'Do not store above 25C'.

In section 10. Date of Revision of Text has been updated to July 2009.
Updated on 28/07/2009 and displayed until 03/08/2009
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   23-Jul-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



6.5       Nature and contents of container

 

White opaque PVC/PE/Aclar blister or white opaque PVC/Aclar/PVC blister with aluminium foil in packs of 28 tablets.

Updated on 10/07/2009 and displayed until 28/07/2009
Reasons for adding or updating:
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   07-Jul-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



6.4 Special precautions for storage

 

For blister packs

Do not store above 30°C. Store in the original package.



10.       DATE OF (PARTIAL) REVISION OF TEXT

 

July 2009June 2008

Updated on 23/07/2008 and displayed until 10/07/2009
Reasons for adding or updating:
  • Change to section 6. 4 - Special Precautions for Storage
Date of revision of text on the SPC:   02-Jun-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



No special precautions for storage

Do not store above 30°C. Store in the original package.

Updated on 26/10/2005 and displayed until 23/07/2008
Reasons for adding or updating:
  • Change to section 10 (date of (partial) revision of the text
Updated on 26/10/2005 and displayed until 26/10/2005
Reasons for adding or updating:
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 14/09/2005 and displayed until 26/10/2005
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Updated on 30/08/2002 and displayed until 14/09/2005
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
Updated on 29/05/2002 and displayed until 30/08/2002
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   naltrexone hydrochloride